Navigation Links
WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting
Date:5/9/2008

successful as of the date of this report. The Company estimates that it has cash available to continue operations only through the latter part of May 2008. If the Company is unable to secure additional funding, it will be forced to take extraordinary business measures which could include filing for bankruptcy, ceasing operations and liquidating assets.

On May 5, 2008, the Company was informed by Robert J. Majteles that he is resigning from the Board of Directors and all of the committees of the Board, effective immediately. The Company intends to reconstitute all of the committees of the Board, such that Mr. William C. Garriock, Dr. Michael Estes and Mr. Gary Goertz, the three remaining independent directors, will be members of each of the committees.

On April 29, 2008, the Company held its Annual Meeting of Shareholders where proposals for shareholders' vote were presented for the following purposes:

(1) to receive and to consider the Company's audited consolidated

financial statements for the year ended December 31, 2007, that have

been prepared in accordance with generally accepted accounting

principles in the United States, together with the report of the

auditors thereon;

(2) to elect directors to serve until the next annual meeting of the

shareholders or until their successors are elected or appointed,

unless the office is vacated earlier;

(3) to appoint Burr, Pilger & Mayer LLP as independent auditors of the

Company and to authorize the directors to fix their remuneration; and

(4) to approve conversion of the secured promissory note in the principal

amount of up to US$5,000,000, previously issued to Abiomed

convertible at Abiomed's option into the Company's common shares at

US$1.748948 per share, subject to adjustments, including any

conversion of interest owed, and approval of the exercise
'/>"/>

SOURCE World Heart Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. WorldHeart 10-KSB Audit Report Includes Going Concern Qualification
2. WorldHeart Schedules Teleconference
3. Cardium Reports on First Quarter 2008 Highlights and Financial Results
4. Novavax Reports First Quarter 2008 Financial Results
5. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
6. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
7. Pharmos Corporation Reports 2008 First Quarter Results
8. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
9. Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008
10. Favrille Reports First Quarter 2008 Financial Results
11. Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Sept. 17, 2014 Intarcia Therapeutics, Inc. ... from a study of the cost and predictability of ... th Annual Meeting of the European Association for ... today, Christian Frois , Ph.D., of Analysis Group, ... of planned Intarcia-sponsored, retrospective studies to characterize the prevalence ...
(Date:9/17/2014)... Mass. , Sept. 17, 2014 ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced that it has been ... and Trademark Office on its unique delivery system ... ) to phagocytic cells for the treatment of ...
(Date:9/17/2014)... September 17, 2014 NASA’s MESSENGER has ... Engineering Corporation is proud to have one of its ... MESSENGER mission is a scientific investigation of the planet ... be sent there, and has provided a vast amount ... V27200 family of latch valves utilize solenoids that also ...
(Date:9/16/2014)... energy from jaw movements has been created by a ... that the device can generate electricity from eating, chewing ... or wearable electronic devices, such as hearing aids, cochlear ... first results of the device,s performance have been published ... Materials and Structures . , Jaw movements have proved ...
Breaking Biology Technology:Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4'Smart material' chin strap harvests energy from chewing 2
... of Toronto has selected quantum physicist Sandu Popescu to receive ... to the field of quantum mechanics. Quantum mechanics is ... predictions such as the fact that any small particle, an ... same time, the story it tells us is so remote ...
... 24, 2011 Juventas Therapeutics is a privately-held, ... of cardiovascular disease.  The Company,s lead product, JVS-100, ... been shown to repair damaged tissue through recruitment ... injury, prevention of ongoing cell death and restoration ...
... Radius Health, Inc. ("Radius") today announced that the ... financing round, including $66 million in equity financing and ... Oxford Finance LLC to a $25 million multi-draw term ... Brookside Capital, Saints Capital, Nordic Bioscience ("Nordic"), and Ipsen ...
Cached Biology Technology:U of Toronto to award quantum mechanics prize to renowned physicist Sandu Popescu 2Juventas Therapeutics Demonstrates JVS-100 Delivery to Patients with Heart Failure is Safe and Provides Clinical Benefit 2Juventas Therapeutics Demonstrates JVS-100 Delivery to Patients with Heart Failure is Safe and Provides Clinical Benefit 3Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 2Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 3Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 4Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study 5
(Date:9/16/2014)... us sick can take up residence in and on ... other troublesome symptom, according to new research at Washington ... On average, healthy individuals carry about five types of ... BioMed Central Biology . The study is the ... in healthy people. , The research was conducted ...
(Date:9/16/2014)... The fall marks a new school year, a new ... International Space Station. In September, SpaceX,s Dragon spacecraft is ... supplies and investigations as part of the company,s fourth ... cargo will be the third suite of research investigations ... in Space (CASIS). With the role of managing the ...
(Date:9/16/2014)... Scotland votes for independence later this week, its Government ... people that fracking is necessary, research has revealed. , ... tracking public perception of shale gas extraction in the ... living north of the border are the least supportive ... research in the University,s School of Geography, said: "The ...
Breaking Biology News(10 mins):Healthy humans make nice homes for viruses 2Healthy humans make nice homes for viruses 3CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3Scottish people most sceptical on fracking, survey shows 2Scottish people most sceptical on fracking, survey shows 3
... in a recently discovered gene is the most ... The discovery by an,international research team provides fresh ... some cases of Parkinson's disease. The,findings could lead ... detect the,mutation in individuals at risk. The research ...
... For,everyone doing or reading a paper about microarray-based experiments,reproductibility, ... results? If I redo the same experiment in one ... recently demonstrated that microarrays experiments performed in different ... reproducibility , as long as standardized protocols are carefully ...
... present a “cautionary tale?about what may go wrong when using ... for cancer. , In the February 16 issue of the ... of Texas M. D. Anderson Cancer Center detail why an ... small sample of blood is unlikely to lead to a ...
Cached Biology News:Scientists detect probable genetic cause of some Parkinson's disease cases 2Scientists detect probable genetic cause of some Parkinson's disease cases 3Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 3New species from old data 2New species from old data 3
... Drummond Scientific has a long ... of microinjection apparatus. Several years ago ... positive displacement microdispenser was being modified ... this unit by redesigning the microdispenser ...
... power supply (Cat. No. Minis 150VS) is ... meet most electrophoresis needs in a personal, ... 150V power supply is capable of running ... designed for individuals to have his/her own ...
BD BioCoat Laminin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of mouse laminin....
... Expression is a powerful application for ... a novel interface, Expression makes complex ... simple. Expression uses the very latest ... in the way sequences are analysed. ...
Biology Products: